13F-HR filed by PRINCIPAL FINANCIAL GROUP INC
PRINCIPAL FINANCIAL GROUP INC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-09, with 2,523 holding rows worth $167,520,022,000.
- Accession
- 0001126328-22-000011
- Filer
- CIK 1126328
- Filed
- 2022-02-09
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A combination report, 4,075 entries on the cover page, a total value of $167,520,022,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $167,520,022,000 with VALUE read as thousands by filing date, 13F file number 028-10106. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerOrigin Asset Management, LLP 028-13785
- reports for this filerPost Advisory Group, LLC 028-12454
- reports for this filerSpectrum Asset Management, Inc 028-11300
- included managerPrincipal Global Investors, LLC 028-01549
- included managerPrincipal Real Estate Investors, LLC 028-10400
- included managerPrincipal Life Insurance Co 028-00793
- included managerPrincipal Financial Services, Inc 028-10107
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TONIX PHARMACEUTICALS HOLDIN | 890260706 | COM | 81,226 | $29,000 | thousands by filing date | |
| ATHERSYS INC | 04744L106 | COM | 32,535 | $29,000 | thousands by filing date | |
| CITIUS PHARMACEUTICALS INC | 17322U207 | COM | 17,470 | $27,000 | thousands by filing date | |
| AUDACY INC | 05070N103 | COM | 10,466 | $27,000 | thousands by filing date | |
| GENIUS BRANDS INTERNATIONAL INC | 37229T301 | COMMON STOCK | 24,757 | $26,000 | thousands by filing date | |
| NORDIC AMERICAN TANKERS LIMI | G65773106 | COM | 14,576 | $25,000 | thousands by filing date | |
| LIBERTY TRIPADVISOR HLDGS IN | 531465102 | COM SER A | 10,909 | $24,000 | thousands by filing date | |
| IBIO INC | 451033203 | COM NEW | 44,918 | $24,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 15,888 | $22,000 | thousands by filing date | |
| ASPIRA WOMENS HEALTH INC | 04537Y109 | COM | 12,296 | $22,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 11,743 | $21,000 | thousands by filing date | |
| Ampio Pharmaceuticals | 03209T109 | COM | 34,357 | $20,000 | thousands by filing date | |
| ALZAMEND NEURO INC | 02262M308 | COM NEW | 10,400 | $20,000 | thousands by filing date | |
| NEWAGE INC | 650194103 | COMMON STOCK | 17,848 | $18,000 | thousands by filing date | |
| MUSTANG BIO INC | 62818Q104 | COM | 10,835 | $18,000 | thousands by filing date | |
| AVALO THERAPEUTICS INC | 05338F108 | CMN | 10,505 | $18,000 | thousands by filing date | |
| LIVEONE INC | 53814X102 | COM | 10,062 | $13,000 | thousands by filing date | |
| MARRONE BIO INNOVATIONS INC | 57165B106 | COM | 17,377 | $13,000 | thousands by filing date | |
| TYME TECHNOLOGIES INC COM | 90238J103 | Stock | 20,612 | $12,000 | thousands by filing date | |
| SURGALIGN HOLDINGS INC | 86882C105 | COM | 16,685 | $12,000 | thousands by filing date | |
| ADAMIS PHARMACEUTICALS CORP | 00547W208 | COM NEW | 17,822 | $11,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 16,715 | $10,000 | thousands by filing date | |
| EROS INTL PLC | G3788M114 | SHS NEW | 24,913 | $6,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001126328-22-000011 | this filing | 2022-02-09 | acceptance time not in the bulk data set |